Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

China's Zai Lab Hong Kong stock jumps most in 16 months on revenue jump

** Hong Kong shares of China's biopharmaceutical group Zai
Lab Ltd  9688.HK  jump 23.9 to HK$16.30, on track for the
biggest one-day pct rise since January 2023
    ** Stock hit the highest since March 14 on the second
session of gain; second biggest pct gainer on Hang Seng
Composite Index  .HSCI  
    ** The drugmaker says its net product revenue amounted to
$87.1 mln for the first quarter, up 39% YoY, with strong balance
sheet having a cash position of $750.8 mln as end-March
    ** Co says first quarter net loss was $53.5 mln, compared to
net loss of $49.1 mln in the same period in 2023
    ** Josh Smiley, president, says Zai Lab is entering a period
of robust growth with the launch of VYVGART at end of last year
and multiple new products and indications expected to launch
near-term 
    ** Hong Kong's healthcare index  .HSCIH  surges 3.1%, Hang
Seng Composite Index  .HSCI  rises 1.3%, Hang Seng Index  .HSI 
adds 1.1%
    ** Hong Kong-listed shares down 25.4% YTD, and U.S. stock
 ZLAB.O  down 39.4% YTD

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))

Recent news on Zai Lab

See all news